COMPANY PROFILE // THE 014 REPORT
Mimedx Group, Inc.
MDXG (Nasdaq) · Formerly: Alynx, Co.
Assembled from 3 government sources in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 25 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✓ SAM registrationpossible match✓ State registrationpossible match✗ LEI✗ IRS return✗ Website✗ Lobbying registration
No LEI, no IRS return, no website, no lobbying registration on record.
MIMEDX GROUP, INC. is an SEC-registered operating company in surgical & medical instruments & apparatus, based in Marietta, GA; listed as MDXG (Nasdaq).[source] It reported revenue of $418.6 million for the fiscal year ended 2025-12-31.[source] It has filed 49 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G, filed 2026-11-12.[source] Its largest institutional holders on 13F filings are Essex Woodlands Management, Inc., BlackRock, Inc., Nantahala Capital Management, LLC (as of 2026-06-30).[source] 25 of 26 lists and sources checked came back clear; the rest are listed with their result.[source]
- red0
- amber0
- info0
- Essex Woodlands Management, Inc.$108.6M
- BlackRock, Inc.$46.8M
- Nantahala Capital Management, LLC$36.7M
- Trigran Investments, Inc.$27.6M
- STATE STREET CORP$21.5M
- VANGUARD CAPITAL MANAGEMENT LLC$20.0M
- PARADIGM CAPITAL MANAGEMENT INC/NY$15.7M
- GEODE CAPITAL MANAGEMENT, LLC$12.1M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Capper Joseph H · Chief Executive Officer (Officer) · latest Form 4 2026-03-06 · filing · LinkedIn search
- DOUG RICE · Chief Financial Officer (Officer) · latest Form 4 2026-03-12 · filing · LinkedIn search
- Hulse William Frank IV · General Counsel and CAO (Officer) · latest Form 4 2026-03-17 · filing · LinkedIn search
- Maersk-Moller Kimberly · Chief Commercial Officer (Officer) · latest Form 4 2026-03-17 · filing · LinkedIn search
- Whitlow Ricci S · Chief Operating Officer (Officer) · latest Form 4 2026-03-06 · filing · LinkedIn search
- BEHRENS M KATHLEEN · Director · latest Form 4 2025-06-23 · filing · LinkedIn search
- BIERMAN JAMES L · Director · latest Form 4 2025-06-23 · filing · LinkedIn search
- HAWKINS WILLIAM A · Director · latest Form 4 2025-06-23 · filing · LinkedIn search
- LAURENCIN CATO T · Director · latest Form 4 2025-06-23 · filing · LinkedIn search
- Newton Todd · Director · latest Form 4 2025-06-23 · filing · LinkedIn search
- Olson Tiffany · Director · latest Form 4 2025-06-23 · filing · LinkedIn search
- PUHY DOROTHY E · Director · latest Form 4 2025-06-23 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Legal counsel, as publicly named
- Greenberg Traurig, P.A. · Exhibit 5.1 legal opinion, S-4 filed 2026-08-25
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 25 CLEAR, 1 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001376339 | source |
| UEIpossible match | LHMTCHSJTFL3 | source |
| CAGEpossible match | 5X6R0 | source |
| EIN | 26-2792552 | source |
| Business address (SEC) | 1775 W OAK COMMONS COURT, NE, MARIETTA, GA, 30062 | source |
Does not exist in the records we hold: LEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-01 · in 101 days · Next 10-K due (period ended 2026-12-31; Large accelerated filer) (computed from the fiscal year end and filer status)
- 2027-04-24 · in 155 days · SAM registration expires (UEI LHMTCHSJTFL3)possible match
- 2027-05-10 · in 171 days · Next 10-Q due (period ended 2027-03-31; Large accelerated filer) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 3841 (surgical & medical instruments & apparatus): 149 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- STRYKER CORP · 101 SEC filings in 12 months · 1 flag · $502.2M federal (possible match)
- ORASURE TECHNOLOGIES INC · 69 SEC filings in 12 months · 2 flags · $480.7M federal (possible match)
- 3M CO · 124 SEC filings in 12 months · $465.5M federal (possible match)
- BOSTON SCIENTIFIC CORP · 110 SEC filings in 12 months · 1 flag · $140.1M federal (possible match)
- CERUS CORP · 71 SEC filings in 12 months · 2 flags · $126.6M federal (possible match)
- BAXTER INTERNATIONAL INC · 84 SEC filings in 12 months · 1 flag · $54.7M federal (possible match)
- Inspire Medical Systems, Inc. · 100 SEC filings in 12 months · 4 flags · $22.3M federal (possible match)
- ACCURAY INC · 103 SEC filings in 12 months · 4 flags · $13.9M federal (possible match)
- NeuroPace Inc · 61 SEC filings in 12 months · $10.3M federal (possible match)
- TELEFLEX INC · 64 SEC filings in 12 months · 1 flag · $9.4M federal (possible match)
- Cytosorbents Corp · 30 SEC filings in 12 months · 4 flags · $5.0M federal (possible match)
- IRADIMED CORP · 70 SEC filings in 12 months · 1 flag · $4.0M federal (possible match)
ADDRESS · ZIP CODE
Location context
Federal contractors nearby in the same code (1)
- MIMEDX GROUP, INC. · SAM Active
registered in SAM.gov with the same ZIP code (30062) and the same primary NAICS code (339113), extract 2026-11-01
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- Anika Therapeutics, Inc. · Capper Joseph H
- Sarepta Therapeutics, Inc. · BEHRENS M KATHLEEN
- TENET HEALTHCARE CORP · BIERMAN JAMES L
- BIOGEN INC. · HAWKINS WILLIAM A
- Bioventus Inc. · HAWKINS WILLIAM A
- Alkermes plc. · LAURENCIN CATO T
- CASTLE BIOSCIENCES INC · Olson Tiffany
EVERY SOURCE · NEWEST FIRST
One timeline
- 2027-04-24 registration SAM registration expiry (UEI LHMTCHSJTFL3) · SAM.gov
- 2026-10-28 filing 425 · SEC EDGAR
- 2026-10-28 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-10-28 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-10-16 filing 425 · SEC EDGAR
- 2026-10-16 filing 8-K items 8.01 · SEC EDGAR
- 2026-09-04 filing EFFECT · SEC EDGAR
- 2026-09-04 filing 424B3 · SEC EDGAR
- 2026-08-25 filing S-4 · SEC EDGAR
- 2026-08-11 filing 425 · SEC EDGAR
- 2026-08-11 filing 8-K/A items 1.01,7.01,9.01 · SEC EDGAR
- 2026-07-30 filing 425 · SEC EDGAR
- 2026-07-30 filing 425 · SEC EDGAR
- 2026-07-29 filing 425 · SEC EDGAR
- 2026-07-29 filing 425 · SEC EDGAR
- 2026-07-29 filing 425 · SEC EDGAR
- 2026-07-29 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-07-29 filing 425 · SEC EDGAR
- 2026-07-29 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-07-29 filing 8-K items 1.01,7.01,9.01 · SEC EDGAR
- 2026-06-16 filing 8-K items 5.03,5.07 · SEC EDGAR
- 2026-04-29 filing DEFA14A · SEC EDGAR
- 2026-04-29 filing ARS · SEC EDGAR
- 2026-04-29 filing Proxy statement · SEC EDGAR
- 2026-04-29 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-04-29 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-04-16 officer change 8-K items 5.02,7.01,9.01 · SEC EDGAR
- 2026-02-25 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-02-25 filing Annual report (10-K) · SEC EDGAR
- 2026-02-18 insider First Form 3/4/5 on record for Whitlow Ricci S (Chief Operating Officer) · SEC Forms 3/4/5
170 earlier entries
- 2026-01-12 filing 8-K items 7.01,9.01
- 2025-11-06 filing 144
- 2025-10-29 filing 8-K items 2.02,7.01,9.01
- 2025-10-29 filing Quarterly report (10-Q)
- 2025-09-03 filing 8-K items 7.01
- 2025-07-30 filing 8-K items 2.02,7.01,9.01
- 2025-07-30 filing Quarterly report (10-Q)
- 2025-07-28 filing S-8
- 2025-07-07 insider First Form 3/4/5 on record for DOUG RICE (Chief Financial Officer)
- 2025-06-23 insider First Form 3/4/5 on record for BEHRENS M KATHLEEN (Director)
- 2025-06-23 insider First Form 3/4/5 on record for BIERMAN JAMES L (Director)
- 2025-06-23 insider First Form 3/4/5 on record for HAWKINS WILLIAM A (Director)
- 2025-06-23 insider First Form 3/4/5 on record for LAURENCIN CATO T (Director)
- 2025-06-23 insider First Form 3/4/5 on record for Newton Todd (Director)
- 2025-06-23 insider First Form 3/4/5 on record for Olson Tiffany (Director)
- 2025-06-23 insider First Form 3/4/5 on record for PUHY DOROTHY E (Director)
- 2025-06-20 filing 8-K items 5.07
- 2025-05-23 filing ARS
- 2025-05-23 filing DEFA14A
- 2025-05-13 filing 8-K items 7.01,9.01
- 2025-05-05 insider First Form 3/4/5 on record for Capper Joseph H (Chief Executive Officer)
- 2025-04-30 filing Proxy statement
- 2025-04-30 filing Quarterly report (10-Q)
- 2025-04-30 filing 8-K items 2.02,7.01,9.01
- 2025-04-10 insider First Form 3/4/5 on record for Hulse William Frank IV (General Counsel and CAO)
- 2025-04-03 insider First Form 3/4/5 on record for Maersk-Moller Kimberly (Chief Commercial Officer)
- 2025-03-10 filing 144
- 2025-02-27 filing 8-K items 7.01,9.01
- 2025-02-26 filing 8-K items 2.02,7.01,9.01
- 2025-02-26 filing Annual report (10-K)
- 2025-01-14 filing 8-K items 7.01,9.01
- 2024-12-16 filing 8-K items 1.01,9.01
- 2024-11-18 filing 8-K items 7.01,9.01
- 2024-10-30 filing 8-K items 2.02,7.01,9.01
- 2024-10-30 filing Quarterly report (10-Q)
- 2024-10-10 filing 144
- 2024-07-31 filing 8-K items 2.02,7.01,9.01
- 2024-07-31 filing Quarterly report (10-Q)
- 2024-06-07 filing 8-K items 5.07
- 2024-06-04 filing UPLOAD
- 2024-05-24 filing CORRESP
- 2024-05-10 filing UPLOAD
- 2024-04-30 filing 8-K items 2.02,7.01,9.01
- 2024-04-30 filing Quarterly report (10-Q)
- 2024-04-23 filing DEFA14A
- 2024-04-23 filing Proxy statement
- 2024-03-27 filing 8-K items 7.01
- 2024-03-04 officer change 8-K items 5.02
- 2024-02-28 filing 8-K items 2.02,7.01,9.01
- 2024-02-28 filing Annual report (10-K)
- 2024-02-20 filing 144
- 2024-02-16 filing 144
- 2024-02-15 filing 144
- 2024-02-14 filing 144
- 2024-01-22 filing 8-K items 1.01,1.02,2.03,7.01,9.01
- 2023-12-28 filing 8-K items 8.01,9.01
- 2023-12-27 filing SC 13D/A
- 2023-11-13 filing 8-K items 7.01,9.01
- 2023-10-30 filing Quarterly report (10-Q)
- 2023-10-30 filing 8-K items 2.02,7.01,9.01
- 2023-09-05 officer change 8-K items 5.02
- 2023-09-05 filing 8-K items 7.01,9.01
- 2023-08-01 filing Quarterly report (10-Q)
- 2023-08-01 filing 8-K items 2.02,7.01,9.01
- 2023-07-25 filing S-8
- 2023-07-25 filing S-8
- 2023-07-05 officer change 8-K items 5.02,7.01
- 2023-06-20 officer change 8-K items 5.02,7.01,9.01
- 2023-06-14 officer change 8-K items 5.02,5.03,5.07,9.01
- 2023-05-16 filing 144
- 2023-05-15 filing 144
- 2023-05-15 filing Proxy statement
- 2023-05-10 filing 144
- 2023-05-10 filing 144
- 2023-05-10 filing 144
- 2023-05-10 filing 144
- 2023-05-04 filing PRE 14A
- 2023-05-04 filing 144
- 2023-05-02 filing 144
- 2023-05-02 filing 8-K items 2.02,7.01,9.01
- 2023-05-02 filing Quarterly report (10-Q)
- 2023-05-01 filing 10-K/A
- 2023-04-25 filing 144
- 2023-04-25 filing 144
- 2023-04-25 filing 144
- 2023-04-25 filing 144
- 2023-04-11 filing 144
- 2023-04-11 filing 144
- 2023-04-11 filing 144
- 2023-03-24 officer change 8-K items 5.02,7.01,9.01
- 2023-03-09 filing S-8
- 2023-02-28 filing 8-K items 2.02,7.01,9.01
- 2023-02-28 filing Annual report (10-K)
- 2023-02-23 filing 8-K items 5.03,9.01
- 2023-01-30 officer change 8-K items 5.02,7.01,9.01
- 2023-01-09 filing 8-K items 2.02,7.01,9.01
- 2023-01-03 officer change 8-K items 5.02,9.01
- 2022-12-16 officer change 8-K items 5.02
- 2022-12-08 filing 8-K items 1.01
- 2022-11-30 filing 8-K items 7.01,9.01
- 2022-11-17 filing 8-K items 7.01,9.01
- 2022-11-02 filing 8-K items 2.02,7.01,9.01
- 2022-11-02 filing Quarterly report (10-Q)
- 2022-09-16 officer change 8-K items 5.02,9.01
- 2022-09-06 officer change 8-K items 5.02,7.01,8.01,9.01
- 2022-08-10 filing 8-K items 7.01,9.01
- 2022-08-02 filing 8-K items 2.02,9.01
- 2022-08-02 filing Quarterly report (10-Q)
- 2022-06-30 filing 8-K items 7.01,9.01
- 2022-06-17 filing S-8
- 2022-06-13 officer change 8-K items 5.02,5.07
- 2022-06-03 filing DEFA14A
- 2022-06-02 filing DEFA14A
- 2022-06-01 filing DEFA14A
- 2022-05-26 filing DEFA14A
- 2022-05-24 filing 8-K items 8.01,9.01
- 2022-05-20 filing DEFA14A
- 2022-05-18 filing DEFA14A
- 2022-05-18 filing DEFA14A
- 2022-05-16 filing DEFA14A
- 2022-05-16 filing DEFA14A
- 2022-05-13 filing DEFA14A
- 2022-05-10 filing 8-K items 7.01,9.01
- 2022-05-09 filing DEFA14A
- 2022-05-09 filing SC 13D/A
- 2022-05-09 filing DEFA14A
- 2022-05-03 filing 8-K items 2.02,9.01
- 2022-05-03 filing Quarterly report (10-Q)
- 2022-04-29 filing DEFA14A
- 2022-04-29 filing 8-K items 7.01,9.01
- 2022-04-28 filing SC 13D
- 2022-04-26 filing Proxy statement
- 2022-03-22 filing 8-K items 7.01,9.01
- 2022-02-28 filing Annual report (10-K)
- 2022-02-28 filing 8-K items 2.02,9.01
- 2022-01-10 filing 8-K items 2.02,7.01,9.01
- 2021-12-07 filing 8-K items 7.01,9.01
- 2021-11-22 filing 8-K items 7.01,9.01
- 2021-11-02 filing 8-K items 2.02,9.01
- 2021-11-02 filing Quarterly report (10-Q)
- 2021-09-13 filing 8-K items 7.01,9.01
- 2021-09-07 filing EFFECT
- 2021-09-02 filing CORRESP
- 2021-09-02 filing UPLOAD
- 2021-08-27 filing S-3
- 2021-08-03 filing 8-K items 2.02,9.01
- 2021-08-03 filing Quarterly report (10-Q)
- 2021-07-07 officer change 8-K items 5.02,9.01
- 2021-06-23 filing 8-K items 2.02,7.01,9.01
- 2021-06-10 filing 8-K items 5.03,9.01
- 2021-06-03 filing 8-K items 5.03,5.07,9.01
- 2021-05-25 filing DEFA14A
- 2021-05-25 filing 8-K items 7.01,9.01
- 2021-05-24 filing DEFA14A
- 2021-05-19 filing DEFA14A
- 2021-05-12 filing DEFA14A
- 2021-05-12 filing 8-K items 7.01,8.01,9.01
- 2021-05-07 filing DEFA14A
- 2021-05-04 filing DFAN14A
- 2021-05-04 filing DFAN14A
- 2021-05-04 filing DEFA14A
- 2021-05-04 filing DEFA14A
- 2021-05-03 filing DEFA14A
- 2021-05-03 filing DEFA14A
- 2021-05-03 filing DEFC14A
- 2021-05-03 filing DEFA14A
- 2021-05-03 filing DEFA14A
- 2021-05-03 filing DEFA14A
- 2021-05-03 filing DEFA14A
- 2021-05-03 filing DEFA14A
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-10-28 (within 30 days) 425 filed
- 2026-10-28 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-10-28 (within 30 days) 10-Q filed
- 2026-10-16 (older) 425 filed (CURRENT REPORT)
- 2026-10-16 (older) 8-K filed: Item 8.01 other event
- 2026-09-04 (older) EFFECT filed
- 2026-09-04 (older) 424B3 filed (PROSPECTUS)
- 2026-08-25 (older) S-4 filed (REGISTRATION STATEMENT)
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:MDXG The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
6 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1376339 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | MDXG / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 262792552 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001376339 | SEC EDGAR / IRS |
| CUSIP | 602496101 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001376339 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $418,630,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-20 06:15 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $48,578,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 06:15 UTC | Report an error |
| Total assets (at 2025-12-31) | $342,653,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 06:15 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $256,548,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 06:15 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $166,121,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 06:15 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 06:15 UTC | Report an error |
| SIC industry | 3841 Surgical & Medical Instruments & Apparatus | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 06:15 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 06:15 UTC | Report an error |
| Business address | 1775 W OAK COMMONS COURT, NE, MARIETTA, GA, 30062 | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 06:15 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 06:15 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | $74,003,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 06:15 UTC | Report an error |
| Long-term debt (at 2025-12-31) | $18,000,000 | 2025-12-31 | 10-K, XBRL LongTermDebt | as filed | 2026-11-20 06:15 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $4,565,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 06:15 UTC | Report an error |
| Form D total offering amount (D filed 2016-01-22) | Indefinite | 2016-01-22 | D | as filed | 2026-11-20 06:15 UTC | Report an error |
| Form D total amount sold (D filed 2016-01-22) | $4,000,000 | 2016-01-22 | D | as filed | 2026-11-20 06:15 UTC | Report an error |
| Form D industry group | Biotechnology | 2016-01-22 | D | as filed | 2026-11-20 06:15 UTC | Report an error |
| Form D revenue range | Over $100,000,000 | 2016-01-22 | D | as filed | 2026-11-20 06:15 UTC | Report an error |
| Form D date of first sale | 2016-01-13 | 2016-01-22 | D | as filed | 2026-11-20 06:15 UTC | Report an error |
| Plan (pension, plan no. 001) | MIMEDX GROUP, INC. 401(K) PLAN: 1,230 participants, assets $102,133,905 | 2025-12-31 | DOL EBSA Form 5500 public datasets (dataset) | as filed | 2026-11-20 06:15 UTC | Report an error |
| Plan (welfare, plan no. 501) | MIMEDX GROUP, INC. WELFARE BENEFITS PLAN: 826 participants | 2025-12-31 | DOL EBSA Form 5500 public datasets (dataset) | as filed | 2026-11-20 06:15 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-10-28 · accession 0001376339-26-000093
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $62,283,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-28 | 0001376339-26-000093 | 2026-11-20 06:15 UTC | Report an error |
| Net income (loss) | -$8,683,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-28 | 0001376339-26-000093 | 2026-11-20 06:15 UTC | Report an error |
| Cash and cash equivalents | $120,791,000 | at 2026-09-30 | 10-Q | 2026-10-28 | 0001376339-26-000093 | 2026-11-20 06:15 UTC | Report an error |
| Debt due in the next 12 months (from an earlier report) | $1,500,000 | at 2025-12-31 | 10-K | 2026-02-25 | 0001376339-26-000011 | 2026-11-20 06:15 UTC | Report an error |
| Debt due in year 2 (from an earlier report) | $1,500,000 | at 2025-12-31 | 10-K | 2026-02-25 | 0001376339-26-000011 | 2026-11-20 06:15 UTC | Report an error |
| Debt due in year 3 (from an earlier report) | $2,000,000 | at 2025-12-31 | 10-K | 2026-02-25 | 0001376339-26-000011 | 2026-11-20 06:15 UTC | Report an error |
| Debt due in year 4 (from an earlier report) | $13,000,000 | at 2025-12-31 | 10-K | 2026-02-25 | 0001376339-26-000011 | 2026-11-20 06:15 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-10-28 Filing 425 filed
- 2026-10-28 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-10-28 Filing 10-Q filed
- 2026-10-16 Filing 425 filed (CURRENT REPORT)
- 2026-10-16 Filing 8-K filed: Item 8.01 other event
- 2026-09-04 Filing EFFECT filed
- 2026-09-04 Filing 424B3 filed (PROSPECTUS)
- 2026-08-25 Filing S-4 filed (REGISTRATION STATEMENT)
- 2026-08-20 Filing Form 5500 received for plan year ending 2025-12-31 (plan no. 501)
- 2026-08-11 Filing 425 filed
- 2026-08-11 Filing 8-K/A filed: Item 1.01 material agreement; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-08-06 Filing Form 5500 received for plan year ending 2025-12-31 (plan no. 001)
- 2026-07-30 Filing 425 filed (FORM 425)
- 2026-07-30 Filing 425 filed (FORM 425)
- 2026-07-29 Filing 425 filed (FORM 425)
- 2026-07-29 Filing 425 filed (FORM 425)
- 2026-07-29 Filing 425 filed
- 2026-07-29 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-07-29 Filing 425 filed
- 2026-07-29 Filing 10-Q filed
- 2026-07-29 Filing 8-K filed: Item 1.01 material agreement; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-06-16 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 5.07 shareholder vote
- 2026-04-29 Filing DEFA14A filed
- 2026-04-29 Filing ARS filed
- 2026-04-29 Filing DEF 14A filed
4 earlier entries
- 2026-04-29 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-04-29 Filing 10-Q filed
- 2013-01-01 Record plan effective date: MIMEDX GROUP, INC. WELFARE BENEFITS PLAN
- 2010-01-01 Record plan effective date: MIMEDX GROUP, INC. 401(K) PLAN
8-K item text, as filed (excerpts)
- 2026-10-28 8-K Item 2.02, Results of Operations and Financial Condition
On October 28, 2026, MiMedx Group, Inc. (the “Company”), issued a press release (the “Earnings Press Release”) announcing its results for the second quarter of 2026. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. It may only be incorporated by reference into another filing under the Exchange… the 8-K · retrieved 2026-11-20 06:15 UTC - 2026-10-28 8-K Item 7.01
Regulation FD On October 28, 2026 at 4:30 PM Eastern Daylight Time, the Company intends to host a conference call and webcast (the “Earnings Call”) to discuss its financial and operating results for the third quarter of 2026. A copy of the slide presentation to be used by the Company in connection with the Earnings Call is attached hereto as Exhibit 99.2 and is incorporated herein by reference. The Company updated its investor presentation on October 28, 2026. A copy of the presentation materials is furnished as Exhibit 99.3 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 7.01, including Exhibit 99.2 attached hereto, and shall not be deemed… the 8-K · retrieved 2026-11-20 06:15 UTC - 2026-08-11 8-K Item 1.01, Entry into a Material Definitive Agreement
Agreement and Plan of Merger On July 29, 2026, MiMedx Group, Inc., a Florida corporation ( “MiMedx”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Sanara MedTech Inc., a Texas corporation (“Sanara”), and Mustang Merger Sub, Inc., a wholly-owned subsidiary of MiMedx (“Merger Subsidiary”), pursuant to which, among other things and subject to the terms and conditions of the Merger Agreement, Merger Subsidiary will be merged with and into Sanara (the “Merger”), with Sanara surviving the Merger as a wholly-owned subsidiary of MiMedx (the “Surviving Corporation”). The Merger and the other transactions contemplated by the Merger Agreement are collectively referred to… the 8-K · retrieved 2026-11-20 06:15 UTC - 2026-08-11 8-K Item 7.01, Regulation FD Disclosure
On July 29, 2026, MiMedx issued a press release announcing its entry into the Merger Agreement (the “Merger Press Release”). A copy of the Merger Press Release is furnished as Exhibit 99.1 and is incorporated herein by reference. MiMedx also intends to issue an investor presentation regarding the Transactions, a copy of which is furnished hereto as Exhibit 99.2 and incorporated into this Item 7.01 by reference. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibits 99.1 and 99.2 are being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the… the 8-K · retrieved 2026-11-20 06:15 UTC - 2026-07-29 8-K Item 2.02, Results of Operations and Financial Condition
On July 29, 2026, MiMedx Group, Inc. (the “Company”), issued a press release (the “Earnings Press Release”) announcing its results for the second quarter of 2026. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. It may only be incorporated by reference into another filing under the Exchange Act… the 8-K · retrieved 2026-11-20 06:15 UTC - 2026-07-29 8-K Item 7.01
Regulation FD On July 29, 2026 at 4:30 PM Eastern Daylight Time, the Company intends to host a conference call and webcast (the “Earnings Call”) to discuss its financial and operating results for the first quarter of 2026. A copy of the slide presentation to be used by the Company in connection with the Earnings Call is attached hereto as Exhibit 99.2 and is incorporated herein by reference. The Company updated its investor presentation on July 29, 2026. A copy of the presentation materials is furnished as Exhibit 99.3 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 7.01, including Exhibit 99.2 attached hereto, and shall not be deemed “filed”… the 8-K · retrieved 2026-11-20 06:15 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
POSSIBLE MATCHES · GROUPED BY SOURCE8. Enforcement by agency
DOJ and agency corporate enforcement (3)
possible match: matched by name only, not merged (3)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchMiMedx Group Inc. · exact legal name · sx:enf:doj:c4f0f6d9-2924-4639-ab19-58b689edc23e Compare
- possible matchMiMedx Group, Inc · exact legal name · sx:enf:seclr:LR-24678 Compare
- possible matchMiMedx Group, Inc. · exact legal name · sx:enf:doj:023d805f-a5cf-4f44-82ab-21b57c799467 Compare
Each record's own page holds its date and the agency document. Matched by exact name only; none of these is counted in the headline.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | Essex Woodlands Management, Inc. | $108,551,709 | 2026-06-30 | SEC 13F filing | 2026-11-20 06:15 UTC | Report an error |
| 2 | BlackRock, Inc. | $46,794,695 | 2026-06-30 | SEC 13F filing | 2026-11-20 06:15 UTC | Report an error |
| 3 | Nantahala Capital Management, LLC | $36,710,150 | 2026-06-30 | SEC 13F filing | 2026-11-20 06:15 UTC | Report an error |
| 4 | Trigran Investments, Inc. | $27,619,014 | 2026-06-30 | SEC 13F filing | 2026-11-20 06:15 UTC | Report an error |
| 5 | STATE STREET CORP | $21,478,842 | 2026-06-30 | SEC 13F filing | 2026-11-20 06:15 UTC | Report an error |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $19,970,154 | 2026-06-30 | SEC 13F filing | 2026-11-20 06:15 UTC | Report an error |
| 7 | PARADIGM CAPITAL MANAGEMENT INC/NY | $15,681,435 | 2026-06-30 | SEC 13F filing | 2026-11-20 06:15 UTC | Report an error |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | $12,105,462 | 2026-06-30 | SEC 13F filing | 2026-11-20 06:15 UTC | Report an error |
| 9 | GOLDMAN SACHS GROUP INC | $10,262,414 | 2026-06-30 | SEC 13F filing | 2026-11-20 06:15 UTC | Report an error |
| 10 | AQR CAPITAL MANAGEMENT LLC | $9,497,969 | 2026-06-30 | SEC 13F filing | 2026-11-20 06:15 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
3 state and city records carry this company's exact name, from 3 sources. Possible matches only.
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchMiMedx Group, Inc. · exact legal name · sx:ctgov:h0aa1041f1d46b8e4 Compare
State licences (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchMIMEDX GROUP INC · exact legal name · sx:elic:ctcred:2881716 Compare
USAspending (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchMIMEDX GROUP, INC. · exact legal name · sx:usaspending:LHMTCHSJTFL3 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1376339.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001376339. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.